Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
52.00
-0.50 (-0.95%)
At close: Mar 6, 2026

Basilea Pharmaceutica AG Statistics

Total Valuation

SWX:BSLN has a market cap or net worth of CHF 639.16 million. The enterprise value is 568.58 million.

Market Cap 639.16M
Enterprise Value 568.58M

Important Dates

The last earnings date was Tuesday, February 17, 2026.

Earnings Date Feb 17, 2026
Ex-Dividend Date n/a

Share Statistics

SWX:BSLN has 12.29 million shares outstanding. The number of shares has decreased by -1.23% in one year.

Current Share Class 12.29M
Shares Outstanding 12.29M
Shares Change (YoY) -1.23%
Shares Change (QoQ) -2.36%
Owned by Insiders (%) 0.68%
Owned by Institutions (%) 34.34%
Float 12.21M

Valuation Ratios

The trailing PE ratio is 16.55 and the forward PE ratio is 13.40.

PE Ratio 16.55
Forward PE 13.40
PS Ratio 2.75
PB Ratio 5.00
P/TBV Ratio 5.01
P/FCF Ratio 10.75
P/OCF Ratio 10.29
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.11, with an EV/FCF ratio of 9.56.

EV / Earnings 14.13
EV / Sales 2.45
EV / EBITDA 10.11
EV / EBIT 10.88
EV / FCF 9.56

Financial Position

The company has a current ratio of 5.11, with a Debt / Equity ratio of 0.70.

Current Ratio 5.11
Quick Ratio 4.53
Debt / Equity 0.70
Debt / EBITDA 1.59
Debt / FCF 1.50
Interest Coverage 15.56

Financial Efficiency

Return on equity (ROE) is 38.52% and return on invested capital (ROIC) is 79.90%.

Return on Equity (ROE) 38.52%
Return on Assets (ROA) 12.10%
Return on Invested Capital (ROIC) 79.90%
Return on Capital Employed (ROCE) 22.45%
Weighted Average Cost of Capital (WACC) 6.33%
Revenue Per Employee 1.23M
Profits Per Employee 212,910
Employee Count 189
Asset Turnover 0.86
Inventory Turnover 5.46

Taxes

In the past 12 months, SWX:BSLN has paid 5.64 million in taxes.

Income Tax 5.64M
Effective Tax Rate 12.28%

Stock Price Statistics

The stock price has increased by +10.64% in the last 52 weeks. The beta is 0.45, so SWX:BSLN's price volatility has been lower than the market average.

Beta (5Y) 0.45
52-Week Price Change +10.64%
50-Day Moving Average 55.01
200-Day Moving Average 50.45
Relative Strength Index (RSI) 38.82
Average Volume (20 Days) 40,915

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SWX:BSLN had revenue of CHF 232.38 million and earned 40.24 million in profits. Earnings per share was 3.14.

Revenue 232.38M
Gross Profit 87.16M
Operating Income 52.25M
Pretax Income 45.88M
Net Income 40.24M
EBITDA 54.06M
EBIT 52.25M
Earnings Per Share (EPS) 3.14
Full Income Statement

Balance Sheet

The company has 159.80 million in cash and 89.22 million in debt, giving a net cash position of 70.58 million or 5.74 per share.

Cash & Cash Equivalents 159.80M
Total Debt 89.22M
Net Cash 70.58M
Net Cash Per Share 5.74
Equity (Book Value) 127.94M
Book Value Per Share 10.41
Working Capital 202.52M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 62.09 million and capital expenditures -2.62 million, giving a free cash flow of 59.47 million.

Operating Cash Flow 62.09M
Capital Expenditures -2.62M
Free Cash Flow 59.47M
FCF Per Share 4.84
Full Cash Flow Statement

Margins

Gross margin is 37.51%, with operating and profit margins of 22.48% and 17.32%.

Gross Margin 37.51%
Operating Margin 22.48%
Pretax Margin 19.74%
Profit Margin 17.32%
EBITDA Margin 23.26%
EBIT Margin 22.48%
FCF Margin 25.59%

Dividends & Yields

SWX:BSLN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 1.23%
Shareholder Yield 1.23%
Earnings Yield 6.30%
FCF Yield 9.30%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SWX:BSLN has an Altman Z-Score of 0.15 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.15
Piotroski F-Score 5